Propanc Biopharma (OTCMKTS:PPCB) Sets New 52-Week High at $2.30

Shares of Propanc Biopharma Inc (OTCMKTS:PPCB) hit a new 52-week high during mid-day trading on Friday . The company traded as high as $2.30 and last traded at $1.99, with a volume of 20404 shares changing hands. The stock had previously closed at $2.20.

The company has a fifty day moving average price of $1.58.

Propanc Biopharma Company Profile (OTCMKTS:PPCB)

Propanc Biopharma, Inc, a development-stage healthcare company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. The company's lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes acting synergistically.

See Also: Different Options Trading Strategies

Receive News & Ratings for Propanc Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Propanc Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.